Israel VC Funds

Hubraum, Deutsche Telekom's tech incubator, is dedicated to fostering innovation in 5G, AI, IoT, and other advanced technologies by bridging the gap between early-stage startups and the extensive resources of Deutsche Telekom. Established in 2012, Hubraum operates from Berlin, Krakow, and Tel Aviv, providing startups with access to mentorship, investment, and Deutsche Telekom's extensive networks, clients, and technology. Hubraum has made over 50 investments, focusing primarily on pre-seed, seed, and Series A stages. Their portfolio includes notable companies like Blinkist, Relayr, and TEXEL, with recent investments in Salvador Technologies and Phelas. These investments highlight Hubraum’s commitment to supporting cutting-edge innovations in various tech sectors including IoT, big data, and AI. The incubator not only offers financial backing but also provides free coworking space and a robust support system to help startups scale their businesses. This comprehensive approach ensures that startups have the necessary resources and guidance to succeed in a competitive tech landscape. Through these initiatives, Hubraum plays a crucial role in driving technological advancement and creating new business opportunities​.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.

i3 Equity Partners, established in 2017 and based in Tel Aviv, is a venture capital firm focused on seed-stage investments in Israeli startups. The firm specializes in the Internet of Things (IoT) sector, supporting companies that are developing cutting-edge technologies in areas like smart cities, industrial IoT, and advanced manufacturing. i3 Equity Partners is backed by a consortium of global industry leaders, including Tel Aviv University, Pitango Venture Capital, Microsoft Ventures, and others, providing startups with not just capital but also strategic guidance and access to a broad network of industry connections. i3 Equity Partners has a strong track record in identifying and nurturing early-stage startups, offering them the resources needed to accelerate time to market and scale internationally. The firm typically invests in companies that demonstrate strong technological innovation and potential for global impact. In addition to financial backing, i3 Equity Partners is deeply involved in mentoring and supporting the growth of its portfolio companies, making it a vital player in Israel's tech ecosystem.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

Impact Venture is a London-based family office with a strong focus on early-stage investments that drive positive social and environmental impact. Their portfolio includes groundbreaking companies like Mango Materials, which produces biodegradable plastics, and Cadence Health, a U.S.-based firm revolutionizing access to over-the-counter birth control. Impact Venture backs startups in sectors like health, sustainability, and tech-driven solutions, including vertical farming and synthetic biology. Geographically, they prioritize investments in regions where these technologies can address large-scale global challenges. Their approach combines patient capital with a hands-on partnership, emphasizing long-term relationships and follow-on funding to help ventures scale successfully. Impact Venture typically provides early-stage funding between £100,000 and £500,000 and invests in bold leaders using advanced technologies to solve urgent societal issues. The firm’s strategy is underpinned by a strong belief in measurable outcomes—both financial and impact-driven—and they prefer startups with strong scientific or technological foundations. The CEO, Kateryna Filippi, leads the team from London, bringing deep expertise in supporting ventures that are reshaping industries​.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Incisive Ventures is a venture capital firm based in Seattle, Washington, founded by Martin Tobias. The firm focuses primarily on pre-seed and seed-stage investments, targeting transformative founders who are working on high-impact, innovative projects. Incisive Ventures has a strong emphasis on sectors such as artificial intelligence (AI), data, SaaS, fintech, and marketplaces. The firm is known for its deep engagement with founders, providing not just capital but also strategic advice and operational support. Incisive Ventures is particularly interested in identifying and supporting startups that demonstrate strong growth potential and the ability to scale efficiently. They maintain a high-conviction, low-volume investment strategy, working closely with a select number of companies to ensure they have the best chance of success. Incisive Ventures also places a significant focus on evaluating startups based on their team dynamics, market size, go-to-market strategies, competition, and unit economics, as discussed in their various insights and webinars. The firm prides itself on being a partner for growth, offering tailored support to help startups navigate the complex early stages of their development​.

INCO Ventures, part of the INCO Group, is a venture capital firm based in Paris, France, specializing in impact investing. Founded in 2011, INCO Ventures focuses on backing startups that drive social and environmental change. The firm manages over €500 million across various funds, including direct management of €110 million and advisory roles for additional funds totaling €450 million. INCO Ventures invests in companies that are shaping a more inclusive and sustainable economy. Their portfolio includes more than 100 impact companies across diverse sectors, such as energy, ecological transitions, digital economy, education, and healthcare​​. They ensure a triple return on investment—economic, social, and environmental—measured using their unique impact assessment tool, INCO Ratings. The broader INCO Group is dedicated to advancing economic opportunities and supporting impact entrepreneurs through initiatives like INCO Academy, INCO Entrepreneurs, and INCO Spaces, which provide skilling programs, support for underrepresented founders, and co-working spaces respectively​.

Incubit Ventures is a deep tech accelerator and incubator based in Beer Sheva, Israel. Founded in 2012, it operates as a subsidiary of Elbit Systems, one of Israel's leading technology firms. Incubit Ventures is focused on investing in early-stage startups that are working on highly innovative and disruptive technologies, particularly those with strong scientific foundations. The firm is part of the Israeli Innovation Authority’s incubators program, providing about $1 million in funding to each startup during the first two years of their development. In addition to financial support, Incubit Ventures offers startups access to Elbit Systems’ extensive resources, including R&D facilities, labs, and expert mentorship. The program is designed to help these startups navigate the complex journey from concept to market-ready products, particularly in industries such as aerospace, healthcare, energy, and advanced materials. Incubit Ventures has a portfolio of over 26 investments, which include companies like NewRocket, developing environmentally friendly rocket engines, and GreenVibe, which is innovating in real-time concrete monitoring technology. The firm aims to bridge the gap between the flexibility of startups and the strength of a large corporate entity, leveraging its connection with Elbit Systems to help these companies achieve commercial success.

Index Ventures is a renowned venture capital firm with dual headquarters in San Francisco and London. Founded in 1996, the firm has a strong track record of investing in transformative companies across various sectors including technology, fintech, healthcare, and consumer products. Notable investments by Index Ventures include some of the biggest names in tech and business today. These include Dropbox, Figma, Slack, Roblox, Adyen, and Deliveroo. The firm has been instrumental in the growth of these companies, providing both financial backing and strategic support​. Index Ventures has raised several significant funds to support its investment strategy. Recently, they closed $3.1 billion in new funds, which are spread across early-stage, growth-stage, and seed-stage investments. This substantial capital allows them to back innovative startups from inception through to maturity​. The firm is known for its deep commitment to the entrepreneurs they support, emphasizing close partnerships and long-term growth. This approach has made Index Ventures a preferred partner for visionary founders looking to scale their businesses globally​.

ING is a global financial institution with a strong focus on sustainable investment, exemplified by initiatives like the world's first sustainability improvement fund. This fund encourages companies to enhance their ESG performance by linking financing terms to sustainability goals. ING collaborates with venture capitalists such as SmartFin, specializing in financial technologies, to support innovation in the fintech sector. The firm has actively divested non-core assets, such as the sale of ING Life Korea to MBK Partners, to streamline its operations and focus on core banking activities. This strategic shift supports ING's broader goal of fostering sustainable development across its investment portfolio. ING's private equity engagements reflect its commitment to environmental and social governance, supporting businesses that align with their sustainability ethos. This approach not only helps ING achieve attractive returns but also contributes positively to global sustainability efforts.

InMotion Ventures is the venture capital arm of Jaguar Land Rover (JLR), focusing on early-stage investments that align with JLR's strategic goals. Established as a key component of JLR’s Open Innovation programme, InMotion Ventures supports startups from Pre-seed to Series A stages in sectors such as climate tech, industrial technology, and enterprise solutions. Their investments aim to accelerate JLR's Reimagine strategy, which focuses on sustainability and innovation in luxury vehicles and services. The fund offers startups not just capital, but also access to a rich ecosystem of innovators and the broader resources of JLR and Tata Group. This includes partnership opportunities, domain expertise, and significant exposure, helping startups gain a competitive edge and achieve growth. InMotion Ventures' portfolio includes companies like Ascend Elements, which focuses on lithium-ion battery recycling, and ev.energy, which connects electric vehicles to grid networks for greener and more efficient charging. Their investment strategy emphasizes supporting technologies that contribute to a sustainable future.

Innodo Ventures was a micro-venture capital fund founded in 2012 and based in Tel Aviv, Israel, specializing in pre-seed investments. The firm was composed of seasoned entrepreneurs and executives who committed their own capital to convert ideas into companies, with expertise spanning intellectual property, technology, sales and marketing, fundraising, and management strategy. The partners had previously created, managed, and sold multimillion-dollar companies, and brought a global ecosystem of investors, partners, and advisers to each portfolio company. The fund invested in the $100,000 to $1 million range across 8 portfolio companies in fintech, cybersecurity, software, and e-commerce. The most significant outcome is BioCatch, a behavioral biometrics company for fraud detection, which achieved a $1.3 billion valuation when Permira acquired a majority stake in a leveraged buyout in 2024. Zeekit, a virtual try-on technology company, was acquired by Walmart for $9 million in 2021. Drippler, a consumer information services company, was acquired for $6.35 million. Sepaya Algo Invest, focused on algorithmic trading, also formed part of the portfolio. The fund co-invested frequently with iAngels, Yanki Margalit, Titanium Investments, UpWest Labs, and Reuven Agassi. Innodo's active investment period ran from approximately 2012 to 2014, with the last tracked investment in Drippler in May 2014. Despite its small size and short deployment window, the fund generated an outsized return through its early position in BioCatch, which became a unicorn more than a decade after the initial investment. The fund is no longer actively operating.

innogy Ventures was the corporate venture capital arm of innogy SE, one of Europe's largest utility companies, founded in 2010 and headquartered in Berlin, Germany. The firm was co-founded and led by Managing Partners Matthias Engel, Thomas W. Thomas, and Veronique Hordemann. innogy Ventures managed the Innogy Renewables Technology Fund I with a final closing of EUR 115 million, investing EUR 1 to 5 million per deal in software-based, data-driven business models aligned with the future utility industry. The firm leads rounds and focused on digital innovation across new energy, Internet of Things, smart city and mobility, renewable energy, and cybersecurity, investing primarily in Europe, Israel, and North America. The portfolio comprised 18 companies across energy technology, sustainability technology, enterprise applications, and environmental tech. Notable investments include eSmart Systems, which raised $34.4 million alongside Energy Impact Partners, Equinor Energy Ventures, and Kongsberg Digital for AI-powered grid inspection; and Akselos, which raised $10 million in a round co-led with Shell Ventures for predictive digital twins in energy assets. Although structured as a corporate VC, innogy Ventures operated with the discipline of a financial investor, prioritizing superior returns through profitable exits over strategic synergy alone. The team of six to ten professionals provided portfolio companies with access to the innogy group's resources for business development. Following E.ON's acquisition of innogy SE, innogy Ventures merged with E.ON's innovation scouting and co-investment teams to form Future Energy Ventures, a EUR 250 million fund continuing to invest in digital and scalable energy technologies from operational hubs in Germany, Israel, and Silicon Valley. The transition preserved the team's investment approach while significantly expanding its capital base.

Innovation Works (IW) is a leading early-stage investor in southwestern Pennsylvania, primarily focused on technology startups. Founded as part of the Ben Franklin Technology Partners network, IW has significantly contributed to the region's economic growth by investing in over 700 companies, which have collectively raised $3.3 billion in follow-on funding and created over 20,000 jobs. Notable sectors in IW's portfolio include robotics, life sciences, software, and clean energy. Some of their prominent investments are in companies like Aurora Innovation and Stack AV, which are part of the thriving robotics and autonomous vehicle industries in Pittsburgh. IW's support extends beyond funding, providing mentorship and resources through their accelerators, AlphaLab and AlphaLab Gear. In 2023, despite a national downturn in venture capital, Pittsburgh's tech sector saw a substantial increase in investments, reaching $3.12 billion, driven by significant activity in automation and AI. This positions Pittsburgh as an emerging tech hub with a growing number of new investors and global technology companies setting up satellite offices in the region. For startups looking to connect with IW, demonstrating innovation and potential for significant impact in high-opportunity markets will align with IW’s investment philosophy.

Insight Partners, founded in 1995 and headquartered in New York City, is a global venture capital and private equity firm renowned for investing in high-growth technology, software, and internet companies. The firm has a vast portfolio of over 1,600 investments, including notable companies like Calm, monday.com, WalkMe, and Checkout.com​. The firm is particularly known for its significant investments across various sectors such as IT infrastructure, cybersecurity, fintech, e-commerce, and DevOps. In 2022, Insight Partners closed its largest fund to date, raising over $20 billion, which underscored its aggressive investment strategy and commitment to high-growth companies​​. Insight Partners employs a hands-on approach to supporting its portfolio companies, offering extensive resources through its Onsite team. This team comprises over 130 experts in areas like sales, marketing, product development, and talent acquisition, dedicated to helping companies scale efficiently. This support has been crucial in helping many of their portfolio companies achieve significant growth and successful exits​. Overall, Insight Partners' combination of substantial financial resources, strategic support, and industry expertise positions it as a leading player in the global venture capital landscape​.

Intango Ventures is a corporate venture capital fund founded in 2017 and headquartered in Tel Aviv, Israel, serving as the investment arm of Intango, a global technology-driven company specializing in digital marketing. The firm invests in early-stage digital marketing, advertising technology, direct-to-consumer, and e-commerce startups at the pre-seed and seed stages. Beginning in 2021, Intango Ventures shifted to a more focused strategy emphasizing synergy and strategic value-add, seeking companies with strong technology foundations, domain expertise, global ambition, and solutions that can be tested on Intango's own platforms. The firm has made approximately 10 investments, with portfolio companies including Leaders, Arena (a marketing and engagement platform), Basepaws (pet genomics), and REIGNN, which was acquired by parent company Intango in 2023. Portfolio companies gain access to Intango's global customer network, media industry partners, and technical and business advice from veterans in digital advertising. Intango Ventures is a partner of Plug and Play's Media and Advertising program, based in Silicon Valley. Beyond capital deployment, Intango Ventures is a community builder within the Israeli startup ecosystem, having founded and sponsored the Digital Marketing Startups Israel community and the D2C Israel Founders Community. These platforms connect founders with global brands, international delegations, peer investors, and event organizers. The firm also operates the Intango Digital Marketing Accelerator for pre-seed startups, providing structured support to companies at the earliest formation stage. This combination of capital, platform access, and community infrastructure positions Intango Ventures as a distinctive operator-led investor in digital marketing and adtech.

InterWest Partners, established in 1979, is a venture capital firm focused on early-stage investments in the information technology and healthcare sectors. Based in Menlo Park, California, the firm has raised over $2.8 billion across ten funds. Throughout its history, InterWest has backed more than 250 companies, achieving 97 IPOs and participating in 95 acquisitions. InterWest Partners IX, one of their notable funds, closed at $606 million and primarily invests in early-stage companies within its targeted sectors. The firm is known for its successful investments in companies such as Doximity, Canva, Braze, and Glaukos. InterWest's approach focuses on partnering with world-class entrepreneurs to build leading companies in IT and healthcare, supporting them through various growth stages. While InterWest Partners is not currently seeking new investments, their legacy includes influential early wins in companies like Xilinx and CIENA in the IT sector, and COR Therapeutics and Ventritex in healthcare, cementing their reputation as a key player in the venture capital landscape.

Inventages Venture Capital, founded in 2000 by Gunnar Weikert, is the venture capital arm of Nestlé, headquartered in Nassau, Bahamas. The firm specializes in health care, life sciences, pharmaceuticals, cosmeceuticals, enabling technologies, and medical devices. Inventages has a broad investment focus, participating in seed, early, mid, and late-stage ventures. Notable investments include Accera, a biotechnology firm focused on therapies for neurodegenerative diseases, and Phagenesis, which develops treatments for dysphagia. Other significant investments are Shield Therapeutics, known for its iron deficiency treatments, and Cognoptix, which is developing diagnostics for Alzheimer's disease​. Inventages typically invests with an average round size of $14 million, demonstrating a strong commitment to substantial funding rounds. The firm is actively involved in guiding its portfolio companies through strategic growth and development stages. Key team members include Gunnar Weikert (Founder and CEO), Thomas Bayerl, and Wolfgang Reichenberger, all bringing significant expertise in venture capital and life sciences to the table. Inventages is particularly noted for its rigorous due diligence process and a strong focus on the commercial viability of scientific innovations. This approach has enabled them to support groundbreaking developments in health and wellness sectors​.

Invesco Private Capital, a division of Invesco, specializes in a broad range of investments, including early-stage ventures, growth capital, buyouts, and private equity. With over 25 years of experience, they leverage a deep network of industry relationships and extensive market insights to identify and support high-potential startups and emerging private equity managers​. Invesco’s notable investments span across various sectors, including technology, healthcare, and financial services. They have been involved in significant ventures and direct investments that align with their strategy of partnering with innovative and scalable companies. Their comprehensive approach includes not only capital investment but also strategic support and operational expertise to help portfolio companies achieve sustainable growth. For more information on their investment strategies and portfolio, you can visit the Invesco website or explore their detailed profiles on investment platforms like PitchBook and Crunchbase.

iSelect Fund is a St. Louis-based venture capital firm focusing on early-stage investments in sectors that have a profound global impact, such as agriculture, food, and healthcare. They invest in companies addressing critical challenges like sustainable food production, improved healthcare delivery, and innovations that enhance human health through better nutrition. iSelect’s portfolio includes over 60 companies, such as Harpe Bioherbicide and Kula Bio, which are tackling sustainability in agriculture through natural and biotechnological solutions. The firm operates with an evergreen fund structure, offering ongoing investment opportunities with low minimums, making venture capital more accessible to accredited investors. Their investment strategy revolves around a balanced, diversified portfolio approach, which allows them to spread risk while supporting transformative companies. iSelect focuses on startups that leverage data, technology, and science to drive innovation, particularly in the areas of food systems, agtech, and health tech. Their emphasis on impact investing means they are highly selective, looking for businesses with the potential for significant financial returns as well as positive societal outcomes. They typically avoid sectors like cannabis and direct-to-consumer models, and focus on companies that can create long-term, scalable change.

Island Capital Partners is an early-stage venture capital firm based in Prince Edward Island, Canada. Founded in 2017, the firm primarily focuses on pre-seed and seed-stage investments, occasionally making pre-pre-seed investments. With a check size ranging from $50K to $500K, Island Capital invests primarily in Atlantic Canada, helping startups across sectors like enterprise software, AgTech, energy, sustainability, and medical devices. As operational investors, Island Capital takes a hands-on approach, actively supporting startups in setting up and scaling their businesses. Some of the notable companies in their portfolio include Coloursmith Labs, Symbodi, and Woveo, reflecting their diverse investment strategy. Island Capital Partners is currently investing through its second fund, continuing its mission to back promising early-stage companies in the region. The firm’s team, which includes partners like Alex MacBeath, Ron Myers, and Katie Arsenault, is dedicated to building strong relationships with founders and providing operational guidance alongside capital​.

Israel HealthCare Ventures (IHCV) is a leading Israeli life sciences venture capital fund founded in 2000 and based in Tel Aviv. The firm has raised two funds, IHCV I and IHCV II, cumulatively investing approximately $135 million across 27 companies in Israel-based startups. Founder and Managing Partner Hadar Ron leads the firm with a hands-on investment approach, preferring to hold board seats in portfolio companies and providing professional advice, ongoing management support, and access to a global network of medical and financial contacts. IHCV invests from seed to later stages across medical devices, biotechnology, pharmaceuticals, life sciences, nanotechnology, and medical-related IT. Approximately 75% of the portfolio consists of medical device companies, with the remaining 25% in pharmaceuticals and biotechnology. Investment checks are typically in the $3 million to $10 million range, and the firm leads rounds. The portfolio spans medical fields including cardiology, orthopedics, oncology, general surgery, gastroenterology, esthetics, and central nervous system disorders, covering therapeutic and diagnostic technologies as well as rehabilitation, drug delivery, and consumer healthcare. Co-investors include Teva Pharmaceuticals. The portfolio has achieved 3 IPOs and 3 acquisitions. The most significant exit is Mazor Robotics, a surgical robotics company acquired by Medtronic for $1.7 billion in September 2018. Gamida Cell, a cell therapy company, completed its NASDAQ IPO in October 2018, raising $139 million in total. Xylo Technologies also achieved an IPO exit. Other notable companies in the portfolio include CorAssist, OrSense, and Optonol. IHCV's two-decade track record in Israeli life sciences reflects the firm's consistent focus on technology that addresses large patient populations with unmet clinical needs. The firm's extensive global medical network enables portfolio companies to access regulatory expertise, clinical partnerships, and commercial relationships across the United States, Europe, and Asia.

J-Ventures is a community-driven global venture capital fund based in Palo Alto, California, founded in 2015 by Oded Hermoni. Operating under the banner of a 'Capitalist Kibbutz,' the J-Ventures Group — comprising J-Ventures Funds, J-Impact, and J-Angels — collectively manages $100 million in assets, with the core fund exceeding $60 million. The firm invests across enterprise software, fintech, cybersecurity, proptech, aviation, gaming, clean technology, agtech, and healthcare, deploying initial checks of $250K to $1 million with follow-on reserves. J-Ventures focuses on US-Israel cross-border opportunities and was the most active foreign VC in Israel in the first half of 2024. The fund has backed 42 active portfolio companies with 6 acquisitions to date. Notable holdings include Descope, Beehero (agtech), Finout (cloud cost management), DataRobot (AI platform), Bria.ai (generative AI), Hidden Level (airspace security), VisbyMedical (rapid diagnostics), and Cents (laundry technology). Exits include Omada Health, which went public in 2025, alongside Conversa Health, Concertio, MachEye, and Ananda. Hermoni has personally invested in more than 70 companies since 2005, with five reaching unicorn status. What distinguishes J-Ventures is its LP structure: the fund is backed by 470 expert members, including 140 serial founders, more than 100 current and former GPs from leading VC firms, and 170 Fortune 500 executives. This community — augmented by a 180-member J-Advisory network of former startup founders, CXOs, and industry executives — provides portfolio companies with operational guidance and market access that extends well beyond capital. The firm provides hands-on support through every stage of a company's growth.

JAL Ventures is a venture capital firm founded in 2004 and based in Herzliya, Israel. Established by Amiram Levinberg and Joshua Levinberg, the firm provides expansion capital to fast-growing, revenue-generating Israeli technology companies with exponential scalability potential. JAL has raised three funds, with Fund II (JAL II) closing at $105 million focused on post-seed and Series A rounds in early-revenue Israeli tech companies. The team of 14 includes Jasmin Kelman as CFO. The firm targets B2B and enterprise markets, backing companies that demonstrate deep, impactful technology and proven product-market fit — typically companies with at least $1 million in revenue or clear initial sales traction. It leads rounds across its portfolio. JAL has invested in 29 companies across enterprise software, SaaS, e-commerce, cybersecurity, and communications. The portfolio has achieved 10 acquisitions — a strong exit rate for an Israel-focused growth fund. Notable exits include Perimeter 81 (cybersecurity, acquired by Check Point Software), Kasamba, Infinipoint, Mintigo, Nanorep, and Opster (search optimization, acquired by Elastic). Current portfolio companies include Datarails (AI-powered financial planning, which raised $70 million following 70% revenue growth), IRP Systems (electric motor technology), Novidea ($50 million Series C insurtech), Solutum (environmental services), Vendict (compliance), and Octup (e-commerce operations). JAL Ventures looks for companies that blend unique technological offerings with domain expertise, committed founding teams, and highly satisfied paying customers. The firm's investment criteria focus on businesses with proven commercial traction and a capital-efficient path to significant scale — an approach shaped by two decades of partnering with Israeli technology companies through multiple market cycles.

Joule Ventures, formerly Janvest Capital Partners, is a seed-stage venture fund specializing in Israeli startups commercializing enterprise-grade solutions for the U.S. market. Their notable investments include BioCatch, a leader in behavioral biometrics, and Coralogix, a provider of AI-driven log analytics. Joule's focus spans DevOps, cybersecurity, fintech, AI/ML, data enablement, and enterprise software. Geographically, they target startups in Israel with a strategic expansion to North America. The fund's strategy emphasizes a partner-only approach, providing founders with direct access to decision-makers and high-level resources from the initial engagement through to commercialization. Joule Ventures typically leads funding rounds and offers an average check size of $1M-$3M, demonstrating a strong commitment to early-stage startups. Key team members include Brian Rosenzweig in Atlanta, Dafna Winocur Biran in Tel Aviv, and Daniel Frankenstein in New York. Brian brings two decades of experience in Israel’s venture market, Dafna offers deep expertise in both Israeli and U.S. markets, and Daniel leverages his background in corporate advisory to support portfolio companies. Startups can approach Joule Ventures through their streamlined process, ensuring efficient support from the first interaction. Their offices in Tel Aviv, New York, and Atlanta facilitate a robust network and resource base for ambitious Israeli founders aiming to penetrate the U.S. enterprise market​.

Javelin Venture Partners is a venture capital firm based in San Francisco, established by experienced entrepreneurs. The firm focuses on early-stage investments, primarily in the late seed and early Series A rounds, with initial check sizes ranging from $500K to $4M. Their investment strategy is geared towards software and technology companies with substantial growth potential and innovative business models. Javelin Venture Partners has a diverse portfolio, including companies like MasterClass, Thumbtack, SmartAsset, and Niantic. They seek founders who exhibit relentless grit, are data-driven, and possess exceptional recruiting and fundraising skills. The firm's evaluation criteria emphasize dynamic and capable founders, capital-efficient business models, and large market opportunities. The leadership team includes Managing Directors Jed Katz and Noah J. Doyle. Jed Katz has a rich history in online commerce and has founded multiple companies. He serves on the boards of Thumbtack, SmartAsset, HighArc, and others. Noah J. Doyle has extensive experience in product management and business development, having directed enterprise products at Google Earth and Google Maps. He sits on the boards of Appvance, Armory, Estimote, and others.

Jerusalem Global Ventures (JGV) is a venture capital firm founded in 1994 by Shlomo Kalish and based in Jerusalem, Israel. The firm holds over $150 million in capital for investment across multiple funds and has announced a $200 million growth equity fund — the Tamar Fund — focused on early-growth-stage, category-leading technology companies. The firm's two leading partners, Shlomo Kalish (Founder and General Partner) and Ranan Grobman (General Partner), have worked together for more than 17 years through multiple market cycles. Daniel Reich serves as Partner and Chief Operating Officer. JGV invests at seed and early stages in communications, information technology, and life sciences, with particular emphasis on AI, cybersecurity, AR/VR, and wearable technologies. It leads rounds across its portfolio. JGV has built a track record of landmark exits over more than three decades investing in Israeli technology. Early exits led by Kalish include Galileo Semiconductors (sold to Marvell), Mellanox Semiconductors (NASDAQ-listed, later acquired by NVIDIA for $6.9 billion), Tradus/QXL (sold to Naspers), Creo (sold to Kodak), Saifun Semiconductors (sold to Spansion), PowerDSine (sold to Microsemi), and Accord Video (sold to Polycom). More recently, the firm backed Moovit — the transit and mobility app acquired by Intel for approximately $900 million in 2020 — JGV's largest recent exit. Current and recent portfolio companies include Lumus (augmented reality optics), Powermat (wireless charging technology), Ginger Software (AI writing assistant), and Wilocity. JGV has developed strong ties with top Israeli entrepreneurs and technologists over 24-plus years of active investing, positioning the firm as a long-standing anchor of the Jerusalem and Israeli startup ecosystem.

iangmen Ventures, established in 2015, is an early-stage venture capital firm based in Beijing, China. The firm focuses on investing in tech-driven startups, particularly those in sectors such as artificial intelligence, healthcare, IoT, and enterprise computing. Their strategy revolves around leveraging technological innovation to unlock business value, primarily targeting early-stage companies that show significant growth potential. Jiangmen has invested in over 50 startups across various industries, including notable companies like Hesai Technology and Heisenberg Robotics. The firm is known for its commitment to backing companies involved in frontier technology such as quantum computing, AI-powered platforms, and advanced manufacturing. One of its more recent investments includes MyTwins.ai, a Hangzhou-based AI platform. Co-founded by Vanessa Gao and Qiang Shen, Jiangmen Ventures takes a hands-on approach with portfolio companies, offering not only financial backing but also strategic mentorship to help startups scale effectively. The firm places a strong emphasis on innovative solutions that can disrupt traditional industries and foster industrial upgrades, particularly in China’s rapidly growing tech landscape.

Johnson & Johnson Innovation is a global network dedicated to empowering healthcare innovators. Founded in 2012, JLABS supports early-stage companies in the pharmaceutical, medical device, consumer, and health tech sectors. Their mission is to foster the development of life-saving and life-enhancing health solutions. JLABS operates across multiple locations, including San Diego, San Francisco, Cambridge, Shanghai, and New York. They offer a robust infrastructure and resources to startups, facilitating collaboration and growth. The initiative has made over 400 investments, including notable companies such as Capstan Therapeutics and Synthis Therapeutics, focusing on biotechnology and medical devices. Their investment strategy emphasizes strategic partnerships and co-investments, working alongside various industry leaders and funding bodies to maximize impact. Recent investments include support for companies like Immunyx, Grapheal, and Neurogene, showcasing their commitment to advancing innovative healthcare solutions.

Jolt Capital is a Paris-based private equity firm specializing in growth-stage investments in deeptech companies across Europe. Founded in 2011, Jolt focuses on supporting technology-rich firms with strong fundamentals, particularly in sectors like photonics, advanced materials, semiconductors, artificial intelligence, and IoT. They typically invest between €10 million and €50 million in businesses that are poised for significant scale, offering both capital and operational expertise to help them expand globally. Jolt Capital stands out by using its proprietary AI platform, Jolt.Ninja, to identify promising investment opportunities. This technology-driven approach allows the firm to discover high-potential companies while avoiding market hype. Their portfolio includes notable companies like Heptagon, NIL Technology, and Verimatrix, all of which leverage cutting-edge technology to address significant market needs. The team at Jolt Capital combines decades of experience in technology, investment, and entrepreneurship, working hands-on with portfolio companies to assist in everything from business strategy to talent acquisition and financial optimization. With a focus on sustainable and responsible investment, Jolt Capital’s mission is to grow European deeptech firms that can transform industries and improve societal outcomes.

Jordache Ventures is the corporate venture capital arm of Jordache Enterprises, the privately held conglomerate founded in 1978 by brothers Joe, Ralph, and Avi Nakash. The Nakash brothers are credited with establishing the designer denim market in the United States and have built Jordache into a $2 billion empire spanning fashion, real estate, hospitality, aviation (Arkia Israeli Airlines, which carries more than 2 million passengers annually), agriculture, and technology. Headquartered in New York, Jordache Ventures is also listed on the Israeli Venture Capital database, reflecting the Nakash family's active cross-border US-Israel investment interests. The firm has made 8 known investments at seed and early stages, predominantly during the 2013 to 2016 period, with checks typically in the $100K to $1 million range. Notable investments include ALICE, a hotel operations platform connecting all service points within a hotel to simplify guest management, which was co-invested alongside Expedia, 645 Ventures, and Tishman Speyer and subsequently acquired by Alpine SG in July 2021. Jordache Ventures has achieved 3 portfolio exits across its investment history. Its investments have spanned software, travel, and food and beverage sectors. Jordache Ventures reflects the Nakash family's interest in applying their extensive experience across hospitality, retail, and international business to technology companies in adjacent markets. The firm has been relatively inactive in new deal activity since 2016, consistent with a harvest-oriented stance as the parent conglomerate continues its broader diversification across fashion brands, real estate holdings, and aviation assets in both the United States and Israel.

Joule Ventures, formerly known as Janvest Capital Partners, is a U.S.-based seed fund focused on investing in Israeli founders who are commercializing enterprise-grade solutions for the U.S. market. The firm, which recently closed a $65 million Fund IV, operates from offices in Tel Aviv, New York, and Atlanta. The firm emphasizes hands-on, high-conviction investments in pre-seed and seed stage companies, particularly in sectors like cybersecurity, AI/ML, fintech, DevOps, data enablement, and software. Notable investments include BioCatch, a leader in behavioral biometrics, and Coralogix, a company providing full-stack observability solutions. Joule Ventures has also backed emerging companies such as Mirato, an AI-driven TPRM platform for financial institutions, and Arnica, a stealth-mode DevSecOps startup. Joule Ventures stands out for its comprehensive support system, offering U.S. market validation, design partner engagement, early customer connections, core team recruitment, cap table and corporate governance guidance, Series A acceleration, and branding and PR support. This extensive involvement helps ensure that their portfolio companies are well-equipped for success in the competitive U.S. enterprise market​.

Journey Ventures is a Tel Aviv-based multi-stage venture capital firm dedicated to the travel technology industry, launched as a joint venture between the Fattal Hotel Group and Spring Ventures. Founded in 2019, the firm targets Israeli and international companies specializing in tourism, travel tech, and the hotel industry that have reached an advanced stage of technological development. The Fattal Hotel Group is Israel's largest hospitality organization, operating more than 200 hotels in 20 countries including the Leonardo hotel chain, a leading European brand. Spring Ventures is a private equity firm traded on the Tel Aviv Stock Exchange, led by Israeli internet entrepreneur Aviv Refuah. The firm is co-founded by Nadav Fattal, VP Marketing at Fattal Hotels Group with more than 10 years of digital marketing and startup experience, and Aviv Refuah, who completed the largest e-commerce transaction in Israel when Spring Ventures sold its online commerce activities to the Azrieli Group in May 2016 for approximately $22 million. Journey Ventures has made 9 known investments at seed and Series A stages with checks in the $500K to $3 million range. Portfolio companies include Lumai, which received a Series A investment in April 2025. A distinctive feature of Journey Ventures is the strategic access it provides to its portfolio: companies gain the Fattal Hotel Group's network of 200-plus hotels across 20 countries as a live testing ground and distribution channel. This combination of institutional hospitality expertise and operating infrastructure gives portfolio companies an unusually direct path to customer validation and commercial traction within the global travel and hospitality sector.

Jovono Ventures, based in Los Angeles and founded in 2016, is a venture capital firm that focuses on investing in paradigm-shifting companies and missionary founders who tackle hard problems or create delightful products. Their portfolio reflects a diverse range of industries, particularly high-tech and enterprise applications. Some of Jovono's notable investments include Anduril Industries, a provider of AI-based defense solutions; Flexport, a digital freight forwarding platform; and DoNotPay, a legal tech company that helps users navigate legal paperwork. Other significant investments are in companies like Sofar Ocean Technologies, QEDIT, and Paragon​. Jovono's investment strategy does not limit itself to specific stages, locations, or industries, but rather focuses on the potential impact and innovation of the companies. This flexibility allows them to back transformative startups at various stages of development. They have made 23 investments so far, including in early-stage companies such as Persist AI and Apollo Brokers. The firm is led by Evan Zimmerman, who brings extensive experience and a strong vision for supporting groundbreaking ventures. Jovono's commitment to building long-term partnerships with founders and helping them navigate their growth journeys sets it apart in the venture capital landscape.

Joy Ventures, now rebranded as Corundum Neuroscience, is a venture capital firm originally founded in 2017 and based in Herzliya, Israel. The firm has transitioned its focus to become a neuroscience-focused venture builder and fund. Under its new identity, Corundum Neuroscience aims to drive innovation in neuroscience by investing in and supporting early-stage companies that develop groundbreaking consumer products and technologies rooted in scientific research. The firm specializes in nurturing startups at various stages, from seeding ideas to advancing them through the critical phases of development. Corundum Neuroscience emphasizes creating products that enhance emotional and mental well-being, reflecting its deep commitment to improving human health through innovative technologies. The firm’s strategy includes providing not just financial backing but also extensive resources such as mentorship, strategic guidance, and access to a network of experts in neuroscience and related fields. With its rebranding, Corundum Neuroscience is positioned to become a leader in the neuroscience sector, fostering the development of cutting-edge solutions that address some of the most pressing challenges in mental health and cognitive sciences.

Jumpspeed Ventures is the first and only micro-venture capital fund dedicated to investing in early-stage startups originating from the Jerusalem, Israel startup ecosystem. Founded in 2013 by Ben Wiener, a New Yorker who relocated to Jerusalem, the firm now manages $40 million across two funds. Fund II raised $20 million specifically for inception-stage Jerusalem-founded tech startups. Jumpspeed invests $250K to $1 million per company, typically leading or co-leading inception rounds, and backs a small handful of new companies each year. Ben Wiener is the sole General Partner. Jumpspeed has made 37 investments and produced two landmark exits: Zoomin, acquired by Salesforce for $450 million, and Robust Intelligence, acquired by Cisco for $400 million — totaling more than $850 million in acquisition value from a micro-fund, an extraordinary return profile. Other portfolio companies include TensorQ, Raily, Lidwave, and NeuroKaire, which received a Series A investment in December 2024. Investment focus spans AI and machine learning, big data, fintech, healthtech, and enterprise software. Wiener evaluates new investments through the H.E.A.R.T. framework: Hypothesis (a strong market thesis), Enormous Stakes (a large problem or opportunity), Alternatives Grossly Inadequate (current solutions fail), Radically Differentiated Solution (a 10x better paradigm shift), and Team Traits and Skills (the credibility to build and sell). Jumpspeed has been featured by VentureBeat and the Leichtag Foundation as a pioneer in validating Jerusalem as a viable tech ecosystem capable of generating returns alongside the more established Tel Aviv startup scene.

Kairos Ventures, established in 2015 and headquartered in Beverly Hills, California, is a venture capital firm focused on investing in early-stage companies across life sciences, physical sciences, and technology sectors. The firm partners with leading scientists and universities to commercialize groundbreaking discoveries. Their portfolio includes notable companies like MemVerge, which aims to merge computer memory and storage using non-volatile RAM, and Neuro-Bio, a biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer's and Parkinson's. Another significant investment is MixComm, a developer of advanced 5G mmWave chips that enhance the efficiency and range of 5G base stations, which was acquired by Sivers Semiconductors in 2022. Kairos Ventures has made over 81 investments and achieved several exits, including Actinobac Biomed and MixComm. The firm is led by founder and CEO James Demetriades, along with a team of experienced professionals who provide strategic support to their portfolio companies.

Kamet Ventures is a venture builder backed by AXA Insurance with an initial commitment of €100 million, founded in 2016 by Stephane Guinet. Based in Paris at 58 rue de Prony with offices in London and Tel Aviv, Kamet operates a fundamentally different model from traditional venture capital: the firm builds companies from scratch using its own research and solution design framework, then recruits entrepreneurs to run them. The five-person team supports founders from launch across business development, technology, legal, and finance. Focus areas are disruptive innovation in insurtech, healthtech, and mobility. Kamet leads rounds in all companies it creates. The firm has made 39 investments and built a portfolio including Padoa (occupational health SaaS), Akur8 (AI insurance pricing), Birdie (elderly care technology), Fixter (car repair marketplace, UK), Air Doctor (travel health insurance), Anorak (life insurance advice), Brightmile (driver safety and mobility), Ibex (AI pathology), Apricity (fertility health), and Setoo (parametric insurance). Kamet achieved 4 portfolio exits, with the most recent being Sayata (commercial insurance platform, acquired September 2025). An earlier acquisition was Qare (telemedicine, acquired by Kamet in April 2019), and the firm also partnered with Korian (eldercare group) in June 2022. Kamet's venture builder model means the firm identifies market gaps in insurance and health, designs solutions and minimum viable products, then finds founding teams to commercialize them — a cycle that positions Kamet as both investor and architect of each company it backs. This approach, anchored by AXA's deep insurance expertise and distribution relationships, gives Kamet-built companies an unusually direct path to industry validation and enterprise customer access from day one.

Katalyst Ventures is a multi-stage venture capital firm that focuses on Applied AI across several sectors, including digital health, enterprise SaaS, and autonomous logistics. Founded by Susan Choe, the firm aims to invest in companies that leverage AI to transform analog processes into scalable, data-driven solutions. Their investment philosophy is centered on supporting businesses that can harness predictive algorithms to drive efficiency and innovation across large markets. The firm's portfolio includes notable companies such as Zipline, which uses drone technology for autonomous deliveries, and Arine, a digital health platform optimizing medication management through AI. Katalyst Ventures typically invests from early to growth stages, offering not just capital but strategic support to help startups scale their operations. Their hands-on approach ensures that startups receive guidance on technology, business development, and international expansion. Katalyst's approach to investing in AI-driven businesses reflects a belief in the transformative potential of data and algorithms, akin to previous technological waves like the internet and mobile. With a focus on practical applications that improve everyday operations, they seek to foster startups that can offer borderless, scalable business models.

Kinnevik is a leading investment company founded in 1936, known for its focus on digital consumer businesses. The firm primarily invests in healthcare, software, marketplaces, and climate tech, partnering with innovative entrepreneurs to drive change and improve the way we work, live, and play. Kinnevik’s portfolio includes over 30 companies, such as Cityblock, Mews, Pleo, and Recursion. Kinnevik operates with a long-term investment horizon, providing substantial support to its portfolio companies from early-stage to growth-phase. The firm emphasizes sustainability and believes in investing in business models that generate significant returns while promoting environmental and social responsibility. The executive team is led by CEO Georgi Ganev, with Samuel Sjöström recently appointed as Chief Strategy Officer. The team includes professionals with deep expertise across various sectors, dedicated to fostering the growth of pioneering companies. Kinnevik's investment approach combines financial backing with active involvement in the strategic direction of its portfolio companies, leveraging nearly a century of investment expertise to build successful, sustainable businesses.

Kitchen Fund is a growth equity firm based in New York that specializes in investing in the restaurant and foodservice sectors. Founded in 2016 by Dan Rowe and Gregory Golkin, the fund focuses on partnering with visionary food and beverage brands that are redefining dining experiences. Kitchen Fund’s investment strategy centers around supporting brands with strong unit economics, authentic brand stories, and the potential for scalable growth. The fund provides not just capital but also strategic guidance in areas such as team building, market expansion, financial analysis, and ESG (Environmental, Social, and Governance) initiatives. Their portfolio includes well-known names like DIG, Miscusi, and Gregorys Coffee, highlighting their commitment to backing brands that are both innovative and culturally resonant. Kitchen Fund places a strong emphasis on authenticity and social impact, seeking out brands that weave the founder's vision into every aspect of the customer experience. They believe that sustainable practices and a strong connection to customers and communities are critical for long-term success​.

KKR, a global investment giant established in 1976, boasts a diverse and robust portfolio. Among their notable tech investments are GoDaddy, FanDuel, and BMC Software, while in energy and healthcare, they back EP Energy, Ridge Natural Resources, BridgeBio Pharma, and Coastal Carolina Hospital. Their industry focus is broad, spanning private equity, infrastructure, real estate, and credit, with a strong emphasis on sustainability and long-term value creation. Geographically, KKR's investments stretch across the Americas, Europe, and Asia Pacific, reflecting their global reach. Their strategy emphasizes patient, disciplined investing, leveraging deep industry knowledge and a network of expert resources to drive growth in their portfolio companies. They are known for leading investment rounds and typically target companies with substantial growth potential and innovative capabilities. KKR often writes large checks, frequently exceeding $100 million, and takes an active role in guiding their investments, offering strategic advice and operational support. Companies looking to attract KKR's interest should highlight their growth potential, solid business models, and alignment with KKR’s strategic objectives. The firm’s leadership includes Henry Kravis and George Roberts, who bring decades of investment expertise and are based in New York. KKR’s team of over 750 investment professionals worldwide ensures that each investment benefits from specialized expertise and strategic insights. For startups and businesses, aligning proposals with KKR’s focus on sustainable growth and value creation is key to engaging successfully with this investment powerhouse.

Kleiner Perkins, based in Menlo Park, California, is one of Silicon Valley’s most storied venture capital firms, known for its early investments in groundbreaking technology companies. Founded in 1972, the firm has backed over 900 ventures, including iconic names like Amazon, Google, and Genentech​. Kleiner Perkins invests primarily in early-stage companies across a broad range of industries including technology, healthcare, and sustainability. Their investment strategy is characterized by partnering closely with founders from the inception of their companies through to IPO and beyond. This approach has led to successful exits such as Netscape, Cerent, and more recently, Google and Amazon​. The firm has seen significant leadership changes in recent years, with the addition of partners like Mamoon Hamid and Ilya Fushman, who have driven a renewed focus on early-stage investments. Recent funds include the $700 million KP19 and the $750 million KP Select fund, which aim to support high-growth companies in sectors like enterprise software, consumer tech, and fintech​. Kleiner Perkins continues to leverage its deep network and extensive experience to support its portfolio companies in areas such as talent acquisition, go-to-market strategies, and marketing. This hands-on approach, combined with their strategic investments, ensures they remain a key player in fostering innovation and driving growth in the tech ecosystem.

Kli Capital, formerly known as BNSG Capital, is a venture capital firm founded in 2014 by Shmuel Gniwisch. Based in New York, the firm focuses on investing in early-stage startups across the U.S., Israel, and emerging markets. Kli Capital targets sectors including healthtech, insurtech/fintech, and consumer products. The firm has made 79 investments and has seen 18 exits. Notable portfolio companies include Hippo Insurance, Imagen Technologies, mPharma, Nym Health, and Cycognito. Kli Capital has recently closed its third fund, aiming to invest $750k to $1.5 million in pre-seed and seed-stage companies. This new fund emphasizes the firm's strategy of backing ambitious founders and providing comprehensive support beyond financial capital. Kli Capital's team includes key figures such as founder and managing partner Shmuel Gniwisch and partner Elias Davis. The firm prides itself on its hands-on approach, leveraging its operational experience to help startups achieve significant growth and success.

Alantra is a prominent international financial services firm offering a range of investment banking and alternative asset management services. Their venture capital focus includes managing funds like the €210 million Klima Energy Transition Fund, which supports innovative energy-tech companies aimed at accelerating the energy transition and combating climate change. This fund, alongside their Solar Fund, underscores Alantra's commitment to sustainable and impactful investments. Alantra's venture capital activities span Europe and North America, targeting high-growth, scalable businesses in sectors like energy transition, cybersecurity, and life sciences. The firm typically invests €8-12 million initially, with the potential to commit up to €21 million per company across follow-on rounds. They prioritize companies with seasoned management teams, proven technologies, and clear commercial traction. The firm boasts a diverse team of professionals based across key European cities, including Madrid, Paris, Bonn, and London, who bring extensive experience in the energy sector and other specialized industries. This expertise is leveraged to provide comprehensive support to their portfolio companies, helping them scale and succeed in competitive markets. Alantra's commitment to responsible investment is highlighted by their compliance with the EU Sustainable Finance Disclosure Regulation and their membership in the Principles of Responsible Investing (PRI). This aligns their interests with those of their investors, fostering sustainable and long-term growth. For startups looking to approach Alantra, highlighting innovative solutions within their focus areas and demonstrating strong market potential will resonate well with their investment strategy​

Kohli Ventures, led by Tej Kohli, is a London-based investment firm with a focus on transformative technologies that drive exponential growth. The firm primarily backs growth-stage ventures in sectors like artificial intelligence, robotics, biotech, e-commerce, and esports, aiming for both high returns and significant social impact. Recent notable investments include biotechnology firm Detraxi and tech giant SpaceX, reflecting its commitment to cutting-edge innovations with global potential. Kohli Ventures prefers control-oriented investments, often acting as the lead or sole investor, allowing founders to focus on scaling rather than continuous fundraising. Their strategy targets companies with a clear path toward an IPO, and they are known for swift decision-making and high liquidity. The firm is particularly active in emerging markets across Asia, Africa, and Latin America. The investment team is anchored by Tej Kohli, whose expertise spans both venture capital and philanthropy. Kohli’s vision extends beyond financial returns, with the fund supporting ventures that can improve lives globally, embodying a double bottom line approach that blends commercial success with humanitarian impact.

Kompas VC is an early-stage venture capital firm that focuses on investing in technologies that drive digital transformation and decarbonization within the building and manufacturing industries. Established in 2021, Kompas VC has offices in Amsterdam, Berlin, Copenhagen, and Tel Aviv. The firm typically invests between €1 million and €5 million in Seed and Series A rounds, continuing to support its portfolio companies throughout their lifecycle. Kompas VC's investment strategy centers on three primary sectors: the built environment, manufacturing, and climate technology. They back innovative startups that aim to reduce carbon emissions, improve energy efficiency, and promote sustainable practices in construction and manufacturing. Their portfolio includes companies like CyanoCapture, which focuses on low-energy carbon capture technology, and Material Evolution, which produces low-carbon cement from industrial waste. The firm is driven by a mission to support the most talented entrepreneurs who are committed to creating a zero-emission, zero-waste building and manufacturing industry. Kompas VC also provides strategic guidance, mentorship, and access to a robust network to help their portfolio companies succeed in competitive markets.